Phase 3 Safety Comparisons for 1.0% Azithromycin in Polymeric Mucoadhesive Eye Drops Versus 0.3% Tobramycin Eye Drops for Bacterial Conjunctivitis
Investigative Ophthalmology and Visual Science - United States
doi 10.1167/iovs.06-1413
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2007
Authors
Publisher
Association for Research in Vision and Ophthalmology (ARVO)